JP2006519160A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519160A5 JP2006519160A5 JP2004541361A JP2004541361A JP2006519160A5 JP 2006519160 A5 JP2006519160 A5 JP 2006519160A5 JP 2004541361 A JP2004541361 A JP 2004541361A JP 2004541361 A JP2004541361 A JP 2004541361A JP 2006519160 A5 JP2006519160 A5 JP 2006519160A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- subtype
- weeks
- administered
- synthetic peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 101710204837 Envelope small membrane protein Proteins 0.000 description 1
- 108010067902 Peptide Library Proteins 0.000 description 1
- 101710088839 Replication initiation protein Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 108091006116 chimeric peptides Proteins 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2002126396/13A RU2237065C2 (ru) | 2002-10-03 | 2002-10-03 | Иммуногенная библиотека химерных пептидов, мимикрирующая генетическое многообразие гипервариабельного района v3 белка оболочки gp120 вируса иммунодефицита человека |
| PCT/RU2003/000421 WO2004031212A1 (en) | 2002-10-03 | 2003-09-25 | Antigenic peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519160A JP2006519160A (ja) | 2006-08-24 |
| JP2006519160A5 true JP2006519160A5 (enExample) | 2007-02-01 |
Family
ID=32067104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004541361A Pending JP2006519160A (ja) | 2002-10-03 | 2003-09-25 | 抗原性ペプチド |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060153865A1 (enExample) |
| EP (1) | EP1558628A4 (enExample) |
| JP (1) | JP2006519160A (enExample) |
| KR (1) | KR20050067411A (enExample) |
| CN (1) | CN1714100A (enExample) |
| AU (1) | AU2003269748A1 (enExample) |
| CA (1) | CA2500401A1 (enExample) |
| NZ (1) | NZ539606A (enExample) |
| RU (1) | RU2237065C2 (enExample) |
| WO (2) | WO2004031212A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1866326A4 (en) * | 2005-03-17 | 2010-06-16 | Primex Clinical Lab Inc | IMMUNOGENES FOR VACCINES AGAINST ANTIGENVARIABLE PATHOGENES AND DISEASES |
| WO2007079755A1 (en) | 2006-01-12 | 2007-07-19 | Janus Beierholm Holding Aps | Reimmunization and antibody design |
| EP2027158B1 (en) * | 2006-05-02 | 2012-09-19 | Carviar ApS | Method for immunizing an avian species |
| AU2008231306A1 (en) * | 2007-03-27 | 2008-10-02 | Duke University | Acute transmitted HIV envelope signatures |
| MX2009013083A (es) * | 2007-06-06 | 2010-01-18 | Danisco Us Inc Genencor Div | Metodos para mejorar multiples propiedades de proteina. |
| WO2009046984A1 (en) * | 2007-10-09 | 2009-04-16 | Technologie Integrale Ltd. | Hiv preventive vaccine based on hiv specific antibodies |
| SG10201503671TA (en) | 2008-12-05 | 2015-06-29 | Takeda Vaccines Inc | Compositions, methods and uses for inducing viral growth |
| WO2011138032A2 (en) * | 2010-05-05 | 2011-11-10 | Artemev, Timur | Universal influenza vaccines and methods for their generation |
| EP2422618A1 (en) * | 2010-08-27 | 2012-02-29 | Technologie Integrale Ltd. | Animal model for the evaluation of the efficacy of an HIV vaccine |
| EP2492279A1 (en) * | 2011-02-25 | 2012-08-29 | Laboratorios Del. Dr. Esteve, S.A. | Rapid immunogen selection method using lentiviral display |
| WO2013040040A1 (en) * | 2011-09-12 | 2013-03-21 | New York University School Of Medicine | Peptides mimicking hiv-1 viral epitopes in the v2 loop for the gp120 surface envelope glycoprotein |
| US10383927B2 (en) | 2015-01-09 | 2019-08-20 | Primex Clinical Laboratories, Inc. | Variable epitope library compositions and methods of therapeutic and prophylactic use |
| EP3990470A1 (en) * | 2019-06-27 | 2022-05-04 | Roche Sequencing Solutions, Inc. | Peptide libraries having enhanced subsequence diversity and methods for use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0728015B1 (en) * | 1992-06-18 | 2006-03-08 | Creagen, Inc. | Method of producing a set of combinatorial polypeptide antigens |
| US5864027A (en) * | 1993-06-07 | 1999-01-26 | Genentech, Inc. | HIV envelope polypeptides |
| GB2282378A (en) * | 1993-09-30 | 1995-04-05 | Merck & Co Inc | Conjugates of epitopes of HIV with a protein complex from Neisseria |
| EP0725838A4 (en) * | 1993-10-26 | 1997-02-26 | United Biomedical Inc | STRUCTURED SYNTHETIC ANTIGAN BANKS AS DIAGNOSTICS, VACCINE AND THERAPEUTIC AGENTS |
| IT1277057B1 (it) * | 1995-12-11 | 1997-11-04 | Tecnogen Scpa | Peptidi antigenici migliorati |
| AP2393A (en) * | 2002-02-08 | 2012-04-04 | Variation Biotechnologies Inc | Immunogenic formulations of variable peptidic epitopes and process for preparation thereof. |
-
2002
- 2002-10-03 RU RU2002126396/13A patent/RU2237065C2/ru not_active IP Right Cessation
-
2003
- 2003-08-19 US US10/529,885 patent/US20060153865A1/en not_active Abandoned
- 2003-09-25 KR KR1020057005874A patent/KR20050067411A/ko not_active Withdrawn
- 2003-09-25 CA CA002500401A patent/CA2500401A1/en not_active Abandoned
- 2003-09-25 EP EP03751670A patent/EP1558628A4/en not_active Withdrawn
- 2003-09-25 WO PCT/RU2003/000421 patent/WO2004031212A1/en not_active Ceased
- 2003-09-25 JP JP2004541361A patent/JP2006519160A/ja active Pending
- 2003-09-25 NZ NZ539606A patent/NZ539606A/en unknown
- 2003-09-25 AU AU2003269748A patent/AU2003269748A1/en not_active Abandoned
- 2003-09-25 CN CNA038255375A patent/CN1714100A/zh active Pending
- 2003-09-29 WO PCT/RU2003/000423 patent/WO2004031226A1/ru not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2136697C1 (ru) | Способ получения олигопептидов | |
| JP2023524054A (ja) | ベータコロナウイルスの予防と治療 | |
| JP2006519160A5 (enExample) | ||
| US4605512A (en) | Small peptides with the specificity of foot and mouth disease viral antigens | |
| JPH05262667A (ja) | ウイルス抗原を用いるワクチン | |
| JP2009067810A (ja) | 合成ペプチドとそれを含むワクチン | |
| JPWO2021168305A5 (enExample) | ||
| Antón et al. | A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis to the three major structural viral proteins | |
| US20060153865A1 (en) | Antigenic peptides | |
| JPH02503916A (ja) | Ｈｉｖエンベロープ蛋白質に関連する合成ペプチド | |
| EP4183417A1 (en) | An immunotherapeutic for prostate cancer treatment | |
| TW200538153A (en) | Feline calicivirus vaccines | |
| IT9019914A1 (it) | Composti immunogenici, il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria | |
| AU2021275403A1 (en) | Antibody that binds specifically to the SARS CoV 2 spike protein, and methods for its manufacture | |
| JPH07505878A (ja) | Ｈｉｖエンベロープ糖タンパク質から誘導された合成ポリペプチド | |
| Volpina et al. | New virus‐specific T‐helper epitopes of foot‐and‐mouth disease viral VP1 protein | |
| JPS58222031A (ja) | 合成ワクチン | |
| Reagan | Modulation of immunity to rabies virus induced by anti-idiotypic antibodies | |
| KR20230156945A (ko) | 백신 조성물 및 이의 사용 방법 | |
| JPS6399018A (ja) | 複合免疫原 | |
| EA008143B1 (ru) | Иммуногенные композиции из вариабельных пептидных эпитопов и способ их получения | |
| US20090252751A1 (en) | Immune adjuvant comprising ubiquinone | |
| PT87239B (pt) | Processo para a preparacao de peptideos | |
| US20060275309A1 (en) | Peptide oligomers for use as hiv vaccines | |
| US20220125913A1 (en) | SYNTHETIC PEPTIDES, AMINO-ACID SEQUENCES, AND COMPOSITIONS USEFUL FOR SARS-CoV-2 DETECTION AND COVID-19 PREVENTION |